REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,305,594 | +4420.8% | 22,595 | +4045.9% | 0.00% | – |
| Q1 2021 | $51,000 | +34.2% | 545 | +79.9% | 0.00% | – |
| Q4 2020 | $38,000 | +58.3% | 303 | +38.4% | 0.00% | – |
| Q3 2020 | $24,000 | -56.4% | 219 | -38.0% | 0.00% | – |
| Q2 2020 | $55,000 | -3.5% | 353 | -16.0% | 0.00% | – |
| Q1 2020 | $57,000 | -90.6% | 420 | -85.8% | 0.00% | – |
| Q4 2019 | $604,000 | +308.1% | 2,957 | +61.2% | 0.00% | – |
| Q3 2019 | $148,000 | -14.5% | 1,834 | +0.3% | 0.00% | – |
| Q2 2019 | $173,000 | +2783.3% | 1,829 | +2512.9% | 0.00% | – |
| Q1 2019 | $6,000 | -68.4% | 70 | -79.0% | 0.00% | – |
| Q4 2018 | $19,000 | +72.7% | 333 | +158.1% | 0.00% | – |
| Q3 2018 | $11,000 | +175.0% | 129 | +14.2% | 0.00% | – |
| Q2 2018 | $4,000 | -96.1% | 113 | -97.8% | 0.00% | – |
| Q2 2016 | $102,000 | – | 5,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |